Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 7Sarcoma 6Lymphoid 6Genitourinary 6Tumor-Agnostic 4Plasma cell 4Other hematologic neoplasm 4CNS 3Thoracic 2Other solid neoplasm 2Myeloid 2Gynecologic 2Breast 2Head & Neck 1Dermatologic 1

Conditions

Multiple Myeloma 4Recurrence 1

Interventions

Dexamethasone 871Bortezomib 457Lenalidomide 456Cyclophosphamide 365Melphalan 272Calcium Dobesilate 263daratumumab 234pomalidomide 208carfilzomib 182fludarabine phosphate 140fludarabine 136Thalidomide 125Peripheral Blood Stem Cell Transplantation 119Filgrastim 114ixazomib 93Mycophenolic Acid 90Granulocyte Colony-Stimulating Factor 89Whole-Body Irradiation 87Busulfan 87dexamethasone acetate 86Tacrolimus 78dexamethasone 21-phosphate 74isatuximab 69Cyclosporine 68auricularum 67Prednisone 65elotuzumab 58belantamab mafodotin 57Antilymphocyte Serum 56Etoposide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × perifosine × Plasma cell × Clear all
NCT00375791 2018-02-28

Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma

AEterna Zentaris

Phase 2 Completed
67 enrolled
Plasma cell

Multiple Myeloma

NCT00401011 2018-02-23

Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients

AEterna Zentaris

Phase 1/2 Completed
84 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT01002248 2018-02-09

Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients

AEterna Zentaris

Phase 3 Terminated
135 enrolled
Plasma cell

Multiple Myeloma

NCT00415064 2012-07-06

Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma

AEterna Zentaris

Phase 1 Completed
32 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡